NLSUI OPAC header image

Guide EU pharmaceutical regulatory law (Record no. 34111)

MARC details
000 -LEADER
fixed length control field 02359nam a2200229Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210624125310.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160316s2012 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789041139016
040 ## - CATALOGING SOURCE
Transcribing agency n
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 344.042330
Item number SHO
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Shorthose Sally
245 ## - TITLE STATEMENT
Title Guide EU pharmaceutical regulatory law
250 ## - EDITION STATEMENT
Edition statement 3rd
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. The Hague
Name of publisher, distributor, etc. Wolter Kluwer
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 640p
Dimensions xlix
365 ## - TRADE PRICE
Price amount Rs. 17,190
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note About the Editor and Authors<br/>Foreword;<br/>List of Abbreviations Brexit;<br/>CHAPTER 1 Overview of European Pharmaceutical Regulatory Requirements Sally Shorthose;<br/>CHAPTER 2 Overview of Intellectual Property Rights Sally Shorthose & Tasmina Goraya;<br/>CHAPTER 3 Clinical Trials Sally Shorthose;<br/>CHAPTER 4 Obtaining a Marketing Authorisation Sally Shorthose & Sarah Faircliffe;<br/>CHAPTER 5 Conditional Marketing Authorisations Sally Shorthose;<br/>CHAPTER 6 Supplementary Protection Certificates Tasmina Goraya;<br/>CHAPTER 7 Paediatrics Sally Shorthose & Sarah Faircliffe;<br/>CHAPTER 8 Advertising Medicinal Products for Human Use Anne-Charlotte Le Bihan, Jean-Baptiste; Thiénot, Sally Shorthose, Sarah Faircliffe, Marc Martens, Nicolas Carbnnelle, Ulf Grundmann, Hanneke Later-Nijland, Mauro Turrini, Gabriel Lidman & Raquel Ballesteros;<br/>CHAPTER 9 Pharmacovigilance Sally Shorthose;<br/>CHAPTER 10 Variations to Marketing Authorisations Tasmina Goraya;<br/>CHAPTER 11 Combination Products Sarah Faircliffe;<br/>CHAPTER 12 Abridged Procedure Hanneke Later-Nijland;<br/>CHAPTER 13 Orphan Drugs Sarah Faircliffe;<br/>CHAPTER 14 Biopharmaceuticals Marc Martens & Nicolas Carbonnelle;<br/>CHAPTER 15 Homeopathic, Herbal, and Traditional Herbal Medicinal Products Hanneke Later-Nijland;<br/>CHAPTER 16 Advanced Therapy Medicinal Products Marc Martens & Nicolas Carbonnelle;<br/>CHAPTER 17 Vaccines Raquel Ballesteros;<br/>CHAPTER 18 Medical Devices Ulf Grundmann, Alexander Csaki, Clarissa Junge-Gierse & David Janiszewski;<br/>CHAPTER 19 Parallel Trade Hanneke Later-Nijland;<br/>CHAPTER 20 Competition Law in the Pharmaceutical Sector José Rivas & Silvia Pronk;<br/>Appendix Guidelines and Publications Table of Cases;<br/>Directives;<br/>Other Legislation;<br/>Regulations;<br/>Index
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element 1. Drug Laws & Legislations - E U 2. Pharmaceutical Medicine - Law & Legislation3. Helath, Care Law - E U
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Bird
-- Bird LLP
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type BOOKs
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
      Not For Loan NLS NLS REFERENCE SECTION 30/05/2017 17190.00 1 344.04233 SHO 30469 30/08/2023 17/02/2018 30/05/2017 BOOKs